3Illum L. Nasal drug delivery-possibilities, problems and solutions [J]. J Control Release, 2003, 87(1-3) : 187-198.
4Rieci EJ, Lunardi LO, Nanelares DM, et al. Sustained release of li- doeaine from Poloxamer 407 gels [ J ]. Int J Pharrn, 2005, 288 (2) : 235 -244.
5Chung H J, Dang HG, Jin WB, et al. Synthesis and eharaeterization of Pluronic ~) grafted ehitosan eopolymer as a novel injectable bioma- terial[J]. Current Applied Physics, 2005, 5(5) : 485-488.
6Nazar H, Fatouros DG, van der Merwe SM, et al. Thermosensitive hydrogels for nasal drug delivery: the formulation and characterisation of systems based on N-trimethyl chitosan chloride [ J ]. Eur J Pharm Biopharm, 2011,77(2) : 225-232.
7Mygind N, Dahl R. Anatomy, physiology and function of the nasal cavities in health and disease [ J ]. Advanced Drug Delivery Reviews, 1998(sl-2) : 3-12.
8Soane RJ, Frier M, Perkins AC, et al. Evaluation of the clearance characteristics of bioadhesive systems in humans [J].Int J Pharm, 1999,178 ( 1 ) : 55-65.
9Cho J, Heuzey MC, B~gin A, et al. Physical gelation of chitosan in the presence of beta-glycemphosphate: the effect of temperature[ J ]. Biomacromolecules, 2005, 6(6): 32-67.
10Chen F, Zhang ZR, Huang Y. Evaluation and modification of N-tri- methyl chitosan chloride nanoparticles as protein carriers [ J ]. lnt J Pharm, 2007, 336(1): 166-173.
